Article
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
Molecular immunology - 1 Jan 2008
Kavanagh David, Richards Anna, Noris Marina, Hauhart Richard, Liszewski M Kathryn, Karpman Diana, Goodship Judith A, Fremeaux-Bacchi Veronique, Remuzzi Giuseppe, Goodship Timothy H J, Atkinson John P
Abstract excerpt
Recent studies have identified mutations in the complement regulatory gene factor I (CFI) that predispose to atypical hemolytic uremic syndrome (aHUS). CFI is a two-chain serine protease in which the light chain carries the catalytic domain while the heavy chain's function is unclear. It downregulates the alternative and classical complement pathways by cleaving the alpha' chains of C3b and C4b in the presence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
